Artificial intelligence-based motion tracking in cancer radiotherapy: A review.
Elahheh SalariJing WangJacob Frank WynneChih-Wei ChangYizhou WuXiaofeng YangPublished in: Journal of applied clinical medical physics (2024)
Radiotherapy aims to deliver a prescribed dose to the tumor while sparing neighboring organs at risk (OARs). Increasingly complex treatment techniques such as volumetric modulated arc therapy (VMAT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), and proton therapy have been developed to deliver doses more precisely to the target. While such technologies have improved dose delivery, the implementation of intra-fraction motion management to verify tumor position at the time of treatment has become increasingly relevant. Artificial intelligence (AI) has recently demonstrated great potential for real-time tracking of tumors during treatment. However, AI-based motion management faces several challenges, including bias in training data, poor transparency, difficult data collection, complex workflows and quality assurance, and limited sample sizes. This review presents the AI algorithms used for chest, abdomen, and pelvic tumor motion management/tracking for radiotherapy and provides a literature summary on the topic. We will also discuss the limitations of these AI-based studies and propose potential improvements.
Keyphrases
- artificial intelligence
- big data
- machine learning
- deep learning
- early stage
- radiation therapy
- locally advanced
- radiation induced
- high speed
- rectal cancer
- healthcare
- primary care
- electronic health record
- squamous cell carcinoma
- climate change
- combination therapy
- human health
- stem cells
- high resolution
- mesenchymal stem cells
- young adults
- virtual reality
- cell therapy
- squamous cell
- data analysis